Clinical Trials Browser

Phase 2 × Sarcoma, Endometrial Stromal × trebananib × Clear all

NCT01210222 2018-02-23

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

35 enrolled 9 charts

GynecologicSarcoma

Sarcoma, Endometrial Stromal